Healthcare -
Biotechnology - NASDAQ - US
$ 10.86
3.23 %
$ 440 M
Market Cap
-2.08
P/E
KROS - OTHER FINANCING ACTIVITIES
Other Financing Activities KROS - Keros Therapeutics, Inc.
3.13 M
LAST VALUE
187.42%
2 YEAR CAGR
-22.86%
5 YEAR CAGR
0.00%
10 YEAR CAGR